According to a recent market study published by Growth Market Reports, titled, “Global Plastic Pre-Filled Syringes Market by Product, By Polymer Type, By Design, By Application, By End-user, and By Region: Size, Share, Trends and Opportunity Analysis, 2015-2030”, the market was valued at US$ 1,843.8 Million in 2021 and is anticipated to expand at a growth rate of 8.8% by 2030.

Pre-filled syringes are increasingly being adopted, as the pharmaceutical industry looks for innovative and practical drug delivery techniques. Several patients self-administer injectable medications at home rather than at the hospital. Pre-filled syringes enable pharmaceutical companies to reduce drug waste and extend product life. Pre-filled syringes have the additional benefit of requiring less overfill. For instance, the USP recommends a 20–25% overfill for a 0.5 ml vial. The required overfill is less than 2% for 0.5 ml. As a result, 18–23% more dosages are produced. Prefills are simple to integrate into a pharmaceutical company's manufacturing line, due to their simple and adaptable processing feature.

Get Sample Report @ https://growthmarketreports.com/request-sample/5247

The global Plastic Pre-Filled Syringes Market has been segmented in terms of product, polymer type, design, application, end-user, and region. In terms of product, the global Plastic Pre-Filled Syringes Market is split into needle-free prefilled syringes and needled prefilled syringes. Based on polymer type, the market is divided into cyclic olefin polymer (COP), cyclic olefin copolymer (COC), and polypropylene (PP). On the basis of design, the market is fragmented into single-chamber prefilled syringes and dual-chamber prefilled syringes. In terms of application, the global plastic pre-filled syringes market is split into diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology, and others. On the basis of end-user, the market is fragmented into hospitals, clinics, home care, and others. Considering regions, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The unexpected advent of the coronavirus pandemic boosted the market. The impact of COVID-19 on a company’s financial situation varies, depending on the industry, size of the company, and other factors. A decrease in revenue, change in consumer behavior, and market volatility are some of the common effects of the pandemic on a company’s finances. Regulatory policies are expected to play a vital role in shaping the dynamics of the plastic prefilled syringes market during the forecast period. Growing investments by governments and key players in the development of pre-filled syringes to eliminate the issue of contamination among patients are expected to boost the demand for pre-filled syringes.

Key Takeaways from the Study:

  • Players in the global Plastic Pre-Filled Syringes Market include BD, Baxter International Inc., Gerresheimer Group, Fresenius SE & Co. KGaA., Nipro Corporation, SCHOTT AG, Taisei Kako Co., Ltd., Terumo Corporation, Plas-Tech Engineering, Inc., and West Pharmaceutical Services, Inc. These players held a major share of the global Plastic Pre-Filled Syringes Market in 2021.
  • Increasing prevalence of chronic diseases, government initiatives for efficient drug delivery, high adoption of pre-filled syringes over traditional syringes, and growing demand for biologics across the globe are key factors that drive the Plastic Pre-Filled Syringes Market.
  • Growing demand for self-injection devices is expected to create opportunities in the coming years.
  • Based on the product, the market is segmented into needle-free prefilled syringes and needled prefilled syringes. The needled prefilled syringe segment is expected to hold a considerable share of the market during the forecast period, as it reduces patient anxiety, providing a high safety level, and ease of use.
  • Based on polymer type, the market is fragmented into cyclic olefin polymer (COP), cyclic olefin copolymer (COC), and polypropylene (PP). The cyclic olefin copolymer (COC)  segment holds a key share of the market. COC is a relatively newer class of polymer, than other polymer types such as polypropylene and polyethylene. It is a high-performance thermoplastic with high chemical inertness, good barrier properties, and a low extractable and leachable profile; therefore, it is suitable for prefilled syringes for IV drugs that are used in hospitals.
  • Based on design, the market is segmented into single-chamber prefilled syringes and dual-chamber prefilled syringes. The dual-chamber prefilled syringe segment is anticipated to expand at a significant CAGR during the forecast period, due to the uniqueness of these syringes. These have two partitioned chambers, where the front chambers are filled with a lyophilized drug product and the back chamber with its diluent, or both chambers are filled with drug products intended for co-delivery.
  • Based on application, the market is segmented into diabetes, rheumatoid arthritis, anaphylaxis, cancer, thrombosis, ophthalmology, and others. The rheumatoid arthritis segment is anticipated to expand at a significant CAGR during the forecast period, as patients with RA prefer subcutaneous (SC) self-injection of MTX as compared to pre-filled pen to pre-filled syringes due to the ease of use, acceptability and satisfaction.
  • Based on end-user, the market is segmented into hospitals, clinics, home care, and others. The home care segment is anticipated to expand at a significant CAGR during the forecast period. As plastic needled prefilled syringes are self-administered due to its ease of use and ability to reduce discomfort, as homecare administration provides the best treatment for patients at home.
  • Based on regions, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.  Europe accounted for a significant share of the market in 2021, due to the changing lifestyle and rising focus on R&D and design and quality of innovative products. Venous thromboembolism is a key cause of death and disability in the UK and the Rest of Europe. In Europe, the rising production of environmentally friendly and safe injecting devices such as pre-filled syringes.

Report Scope

Report Metric

Details

Market Value in 2021

US$ 1,843.8 Million

Market Growth Rate (from 2022 to 2030)

8.8%

Historical Data

2015 & 2020

Base Year

2021

Forecast Period

2022 – 2030

Units Considered

Value (US$ Million)

Market Segments

By Product, By Polymer Type, By Design, By Application, By End-user, and By Region

Key Companies Profiled

BD, Baxter International Inc., Gerresheimer Group, Fresenius SE & Co. KGaA., Nipro Corporation, SCHOTT AG, Taisei Kako Co., Ltd., Terumo Corporation, Plas-Tech Engineering, Inc., and West Pharmaceutical Services, Inc.

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.

Target Audience

  • Supply-side: Vendor, Manufacturer, Distributors, Supplier, Retailer.
  • Regulatory Side: Concerned government authorities, and other approved regulatory bodies.